Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Globus Medical’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054450
FAQ
- What is Globus Medical's D&A?
- Globus Medical (GMED) reported D&A of $69.5M in Q2 2026.
- How has Globus Medical's D&A changed year-over-year?
- Globus Medical's D&A decreased by 1.6% year-over-year, from $70.63M to $69.5M.
- What is the long-term trend for Globus Medical's D&A?
- Over 4 years (2021 to 2025), Globus Medical's D&A has grown at a 41.1% compound annual growth rate (CAGR), from $69.87M to $276.84M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Globus Medical's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude